Sign Up to like & get
recommendations!
2
Published in 2022 at "Cell reports"
DOI: 10.1016/j.celrep.2022.110436
Abstract: HIV-1 clade C envelope immunogens that elicit both neutralizing and non-neutralizing V1V2-scaffold-specific antibodies (protective correlates from RV144 human trial) are urgently needed due to the prevalence of this clade in the most impacted regions worldwide.…
read more here.
Keywords:
scaffold antibodies;
clade;
autologous neutralizing;
v1v2 scaffold ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Science Translational Medicine"
DOI: 10.1126/scitranslmed.abq4490
Abstract: Early initiation of antiretroviral therapy (ART) alters viral rebound kinetics after analytic treatment interruption (ATI) and may play a role in promoting HIV-1 remission. Autologous neutralizing antibodies (aNAbs) represent a key adaptive immune response in…
read more here.
Keywords:
hiv;
neutralizing antibodies;
art;
treatment ... See more keywords